Short note
Pipecolic acid is oxidized by renal and hepatic peroxisomes: Implications for Zellweger's cerebro-hepato-renal syndrome (CHRS)

https://doi.org/10.1016/0014-4827(86)90475-1Get rights and content

Abstract

Increased levels of pipecolic acid have been reported in patients with cerebro-hepatorenal syndrom (CHRS) of Zellweger and the general deficiency of peroxisomal function has been implicated in its pathogenesis. We have therefore investigated the capacity of normal peroxisomes to metabolize pipecolic acid. Highly purified peroxisomes were obtained from rat liver and rat and beef kidney cortex by a recently developed method using metrizamide gradients and a vertical rotor. These preparations oxidized d,l-pipecolic acid as evidenced by the measurement of H2O2 production. Incubation with either the d- or l-isomer revealed that almost exclusively d-pipecolate is oxidized. The specific activities proved to be 20–50 times higher in renal than in hepatic peroxisomes. A commercially available crystalline suspension of d-amino acid oxidase from porcine kidney also oxidized the pipecolic acid with the following rates 54:36:1 respectively for d-:,d,l-:l-isomers. Incubation of vibratome sections of rat kidney and liver in a medium containing d-pipecolic acid and cerous ions, revealed electron-dense deposits over the matrix of peroxisomes confirming the localization also by fine structural cytochemistry.

These observations demonstrate the capability of mammalian peroxisomes to oxidize pipecolic acid and suggest that the absence or deficiency of peroxisomal d-amino acid oxidase may be implicated in the pathogenesis of hyperpipecolatemia in Zellweger's CHRS.

References (23)

  • J Dancis et al.

    Comp biochem physiol

    (1982)
  • DW Smith et al.

    J pediatr

    (1965)
  • E Passarge et al.

    J ped

    (1967)
  • YF Chang

    Biochem biophys res commun

    (1976)
  • YF Chang

    J neurochem

    (1978)
  • H Nishio et al.

    Neurochem res

    (1981)
  • JMF Trijbels et al.

    J inher metab dis

    (1979)
  • DW Arneson et al.

    Arch neurol

    (1982)
  • SL Goldfischer et al.

    Science

    (1973)
  • RI Kelley

    Am j med genetics

    (1983)
  • A Völkl et al.

    Eur j biochem

    (1985)
  • Cited by (32)

    • Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE)

      2017, Biochimica et Biophysica Acta - Molecular Basis of Disease
      Citation Excerpt :

      In point of fact, the 15N-AAA APE (%) in the plasma of mice injected with [ε-15N] lysine was not statistically different from the natural 15N-AAA levels found in mice injected with unlabelled lysine. This uncertainty about the functionality (or even existence) of the downstream steps of the pipecolate pathway is in keeping with recent similar experiment of lysine catabolic pathways [15] as well as with previous reports on low liver and kidney PIPOX activity [15,25,26]; it may be that pipecolic acid acts as a substrate in other cellular pathways yet to be delineated. Indeed, ε and α-15N-glutamic acid were not detected in blood samples but were found in similar levels in liver and brain at ~ 6 and 5 APE (%), respectively (data not shown).

    • Peroxisomes and oxidative stress

      2006, Biochimica et Biophysica Acta - Molecular Cell Research
    • l-Pipecolic acid oxidation in rat: subcellular localization and developmental study

      1993, Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular
    View all citing articles on Scopus

    An abstract of this report is presented at the 25th annual meeting of the American Society of Cell Biology in Atlanta, Georgia, USA, November 1985.

    This study was supported by a grant (Fa 146/1–2) from the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, FRG.

    View full text